The global cell analysis market size was estimated at USD 29.2 billion in 2023 and is projected to grow at a CAGR of 9.8% from 2024 to 2030. This growth can be attributed to the increasing prevalence of chronic diseases, advancements in cell analysis technologies, and the growing number of drug discovery activities. Cell analysis has emerged as an important tool for the identification of potential therapies and treatments for chronic diseases. Thus, the increasing prevalence of chronic diseases such as cardiovascular diseases, cancer, autoimmune diseases, neurological disorders, and others can drive the demand for cell analysis. According to the American Cancer Society, over 2 million new cancer cases are expected to be diagnosed in the U.S. in 2024.

Cell analysis has witnessed an increase in its application, from early-stage cancer diagnostics to the development of cancer-associated therapies and tools, which has further increased its popularity in the oncology sector. The players operating in the oncology sector are increasing their efforts for advancements in cell analysis to develop advanced therapies and treatments. For instance, in March 2024, a cancer diagnostics company, Serum Detect, was set to launch the T-cell analysis approach for early cancer detection at the American Association for Cancer Research (AACR). Such increasing efforts by healthcare companies to increase the application of cell analysis are anticipated to drive market growth over the forecast period.

Gather more insights about the market drivers, restrains and growth of the Cell Analysis Market

Key Cell Analysis Company Insights

Key players operating in the cell analysis market are undertaking various initiatives to strengthen their market presence and increase the reach of their products and services. Strategies such as expansion activities and partnerships are playing a key role in propelling market growth.

Recent Developments

• In February 2024, Cell Microsystems & OMNI Life Science announced a partnership to launch three innovative cell analysis solutions in North America. The products are expected to accelerate innovation and enhance research capabilities.

• In February 2024, 10X Genomics announced the launch of GEM-X, comprising two single-cell gene assays-Chromium Single Cell Gene Expression 3'v4 and Chromium Single Cell Immune Profiling 5'v3, helping 10X Genomics to expand its single-cell technology products portfolio.

• In February 2024, Takara Bio USA, Inc announced the launch of two single-cell solutions, Shasta Total RNA-Seq Kit and Shasta Whole-Genome Amplification Kit.

• In February 2024, Singleron Biotechnologies announced the opening of its labs in Ann Arbor, Michigan, U.S. The company planned to offer single-cell analysis service, comprehensive solutions from tissue dissociation, single-cell multi-omic analysis, single cell reagent kits, automation instruments, to bioinformatics support.

• In August 2023, Cell Microsystems acquired Fluxion Biosciences to enhance its cell analysis product and service portfolio. This acquisition adds Fluxion Biosciences’s BioFlux, IonFlux, and IsoFlux products to Cell Microsystems’s portfolio to offer innovative cell analysis solutions to life science professionals and researchers.

Global Cell Analysis Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global cell analysis market report based on product & service, technique, process, End-use, and region.

Product & Service Outlook (Revenue, USD Million, 2018 - 2030)

• Reagents & Consumables

• Instruments

• Accessories

• Software

• Service

Technique Outlook (Revenue, USD Million, 2018 - 2030)

• Flow Cytometry

• PCR

• Cell Microarrays

• Microscopy

• Spectrophotometry

• High Content-Screening

• Other Techniques

• Process Outlook (Revenue, USD Million, 2018 - 2030)

• Cell Identification

• Cell Viability

• Cell Signaling Pathways

• Cell Proliferation

• Cell Counting

• Cell Interaction

• Cell Structure Study

• Single-cell Analysis

• Others

End-use Outlook (Revenue, USD Million, 2018 - 2030)

• Pharmaceutical & Biotechnology Companies

• Hospitals & Clinical Testing Laboratories

• Academic & Research Institutes

• Other

Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o UK

o France

o Italy

o Spain

o Denmark

o Sweden

o Norway

• Asia Pacific

o China

o Japan

o India

o South Korea

o Australia

o Thailand

• Latin America

o Brazil

o Argentina

• MEA

o South Africa

o Saudi Arabia

o UAE

o Kuwait

Order a free sample PDF of the Cell Analysis Market Intelligence Study, published by Grand View Research.